EXAMINE & ENDURE Study Results.

In 2014, Takeda released results from the highly anticipated EXAMINE & ENDURE trials, which investigated the durability, efficacy and safety of Alogliptin vs Glipizide, along with the cardiovascular outcomes in Alogliptin patients with Type II Diabetes Mellitus and recent Acute Coronary Syndrome.

The challenge was to present this data to an audience of specialist healthcare professionals, in a way that provided a comprehensive and accurate overview of the study results that could be showcased at global congress and Takeda sponsored booths around the world.

Blue Dog worked with the Alogliptin global scientific communications team and a top UK cardiologist to film and produce an interactive augmented reality video, which concisely presents the clinical study data whilst steering away from the traditional clinical slide deck format.